Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Which Dividend Aristocrats Etf Has Highest Expense Ratio
Identify Which Dividend Aristocrats ETF Has Highest Expense Ratio and discuss implications for costs and performance.
27,586 articles
Social Security’s Billion Giveaway Hits a Roadblock
A looming 2027 COLA could lift benefits by billions, but inflation momentum and policy hurdles threaten social securi...
Anthropic Rolls Claude Mythos: Safer Fable 5 for Public
Anthropic unveils Claude Mythos in a full cybersecurity-focused release, paired with a safer Fable 5 for general user...
More Plaintiffs Join Unison HEI Lawsuit in Colorado
A federal class-action in Colorado expands as new homeowners join the suit against Unison. Plaintiffs allege Unison's...
Popular Stocks Sell Before AI Slumps: 2 Picks
As the AI boom draws big bets, some stocks may retreat. Learn which two popular AI shares could retreat and how to po...
Social Security's 2027 COLA on Track to Be Historic
This article explores the potential for a historic social security's 2027 cola and what it could mean for retirees an...
Fox Announces Plan to Acquire Roku in a $22 Billion Deal
Fox said it will acquire Roku in a $22 billion cash-and-stock deal, at $160 per Roku share. The transaction is slated...
Transcript: Jean Eric Salata’s EQT Leadership and Investing
Explore how Jean Eric Salata leads EQT Group to build durable value across private equity and beyond. This article di...
Transportation Stock After Director: Is via a Buy?
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Stock Market Today, June: Eos Energy Partners Battery Boom
In today’s stock market today, june session, Eos Energy Enterprises ignited buying as it announced an exclusive long-...
MiB: Seth Klarman and the Baupost Group Investment Philosophy
Discover the quiet power of Baupost. This article unpacks Seth Klarman’s patient, risk-aware value approach, how the ...
Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status